Pricing Log in Create free account

Pharvaris N.V. (PHVS) vs Palvella Therapeutics, Inc. (PVLA)

Pharvaris N.V. and Palvella Therapeutics, Inc. are both Biotechnology companies. Pharvaris N.V. and Palvella Therapeutics, Inc. are of similar size ($2.3B and $2.3B). Across the 10 metrics below, Palvella Therapeutics, Inc. leads on 9 and Pharvaris N.V. on 1.

Valuation

Metric PHVS PVLA Biotechnology median
P/E n/m n/m 10.26
P/S n/m 54.15 9.18
P/B 6.38 10.38 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 48.15 8.98
Earnings yield (9.30%) (3.08%) (34.89%)
Free cash flow yield (7.98%) (1.43%) (24.52%)

Profitability

Metric PHVS PVLA Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (71.50%) (46.63%) (50.12%)
Return on assets (64.43%) (37.70%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PHVS PVLA Biotechnology median
Revenue growth (TTM) — 146.67% 6.26%
EPS growth (last fiscal year) (25.37%) 52.62% 29.88%
Revenue growth, 5-year CAGR — 8.03% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PHVS PVLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.94 21.18 4.89
Net debt to EBITDA 1.72 1.50 1.01

Dividend

Metric PHVS PVLA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PHVS PVLA Biotechnology median
Market cap 2.28b 2.26b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack